GENGRAF Reviews

Average Rating: 4.0 (1 Ratings)

Filter Results

Compare GENGRAF with similar:

 Type: Rx Drug
  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR GENGRAFCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 4  atopic dermatitis/eczema Stomach cramps until I started taking it with milk. Lower back weakness and knee pain. This drug has helped me tremendously. My skin was so bad for months and months. I went to 6 different dermas here in NJ with no help. I have a bagful of creams, none of which would help me. Finally someone suggested i go to NYU. Right away he gave me cyclo. I started with 250 mg a day, last month diminished it to 225 and just this week dwindled to 200. I want to get off this drug only because I hate taking anything with so many side effects for too long. But, I am so afraid it will come back again. The worst of it is the dryness and itchiness and redness of my face and eyelids. It is starting again to get a little itchy, but maybe because it is winter. No moisturizer really helps, even vaseline. If anyone has any suggestions as to what works on your skin for this condition, please email. F 47 4 days
12/31/2007
Email
  

GENGRAF  (CYCLOSPORINE):  Cyclosporine is used to prevent organ rejection in people who have received a liver, kidney, or heart transplant. It is usually taken along with other medications to allow your new organ to function normally. Cyclosporine is also used to treat severe cases of rheumatoid arthritis and plaque psoriasis. In these conditions, the body's defense system (immune system) attacks healthy tissues. Cyclosporine belongs to a class of drugs known as immunosuppressants. It works by weakening the immune system to help your body accept the new organ as if it were your own (in the case of an organ transplant) and to prevent further damage to your joints (in the case of rheumatoid arthritis) or skin (in the case of psoriasis).   (Sources: U.S. Centers for Medicare Services, FDA)

BACK TO TOP